• Zamawiaj do paczkomatu
  • Płać wygodnie
  • Obniżka
Pharmacotherapy: A Pathophysiologic Approach, Tenth Edition

Pharmacotherapy: A Pathophysiologic Approach, Tenth Edition

9781259587481
1 152,84 zł
1 037,55 zł Zniżka 115,29 zł Brutto
Najniższa cena w okresie 30 dni przed promocją: 1 037,55 zł
Ilość
Produkt niedostępny
Nakład wyczerpany (niedostępny u wydawcy)

  Dostawa

Wybierz Paczkomat Inpost, Orlen Paczkę, DPD lub Pocztę Polską. Kliknij po więcej szczegółów

  Płatność

Zapłać szybkim przelewem, kartą płatniczą lub za pobraniem. Kliknij po więcej szczegółów

  Zwroty

Jeżeli jesteś konsumentem możesz zwrócić towar w ciągu 14 dni. Kliknij po więcej szczegółów

Opis

The landmark text on how to achieve optimal patient outcomes through evidence-based medication therapy  <?xml::namespace prefix = o ns = urn::schemas-microsoft-com::office::office />

Pharmacotherapy:: A Pathophysiologic Approach is written to help readers advance the quality of patient care through evidence-based medication therapy derived from sound pharmacotherapeutic principles. The scope of this trusted classic goes beyond drug indications and dosages to include the initial selection, proper administration, and monitoring of drugs. Readers will find everything they need to provide safe, effective drug therapy across the full range of therapeutic categories.

This edition is enriched by more than 300 expert contributors, and every chapter has been revised and updated to reflect the latest in evidence-based information and recommendations.  Important features such as Key Concepts at the beginning of each chapter, Clinical Presentation tables that summarize disease signs and symptoms, and Clinical Controversies boxes that examine the complicated issues faced by students and clinicians in providing drug therapy make this text an essential learning tool for students,  patient-focused pharmacists, and other health care providers.

 

·         A section on personalized pharmacotherapy appears in most sections

·         All diagnostic flow diagrams, treatment algorithms, dosing guideline recommendations, and monitoring approaches are in full color to clearly distinguish treatment pathways

·         New drug monitoring tables have been added

·         Most of the disease-oriented chapters have incorporated evidence-based treatment guidelines that when available, include ratings of the level of evidence to support the key therapeutic approaches

·         Twenty-four online-only chapters are available at www.pharmacotherapyonline.com

Szczegóły produktu
58587
9781259587481
9781259587481

Opis

Rok wydania
2017
Numer wydania
10
Oprawa
twarda
Liczba stron
2512
Wymiary (mm)
229 x 282
Waga (g)
5130
  • Contributors
    Foreword
    Foreword to the First Edition
    Preface
    Section 1 Foundation Issues
    e1. Health Literacy and Medication Use
    e2. Cultural Competency
    e3. Medication Safety Principles and Practices
    e4. Clinical Pharmacokinetics and Pharmacodynamics
    e5. Pharmacogenetics
    e6. Pediatrics
    e7. Geriatrics
    e8. Palliative Care
    e9. Clinical Toxicology
    e10. Clinical Management of Potential Bioterrorism-related Conditions
    Section 2 Cardiovascular Disorders
    e11. Cardiovascular Testing
    12. Cardiac Arrest
    13. Hypertension
    14. Chronic Heart Failure
    15. Acute Decompensated Heart Failure
    16. Stable Ischemic Heart Disease
    17. Acute Coronary Syndromes
    18. The Arrhythmias
    19. Venous Thromboembolism
    20. Stroke
    21. Dyslipidemia
    e22. Peripheral Arterial Disease
    23. Use of Vasopressors and Inotropes in the Pharmacotherapy of Shock
    24. Hypovolemic Shock
    e25. Introduction to Pulmonary Function Testing
    Section 3 Respiratory Disorders
    26. Asthma
    27. Chronic Obstructive Pulmonary Disease
    28. Pulmonary Arterial Hypertension
    29. Cystic Fibrosis
    e30. Drug-Induced Pulmonary Diseases
    Section 4 Gastrointestinal Disorders
    e31. Evaluation of the Gastrointestinal Tract
    32. Gastroesophageal Reflux Disease
    33. Peptic Ulcer Disease and Related Disorders
    34. Inflammatory Bowel Disease
    35. Nausea and Vomiting
    36. Diarrhea, Constipation, and Irritable Bowel Syndrome
    37. Portal Hypertension and Cirrhosis
    e38. Drug-Induced Liver Disease
    39. Pancreatitis
    40. Viral Hepatitis
    41. Celiac Disease
    Section 5 Renal Disorders
    e42. Evaluation of Kidney Function
    43. Acute Kidney Injury
    44. Chronic Kidney Disease
    45. Hemodialysis and Peritoneal Dialysis
    46. Drug-Induced Kidney Disease
    47. Glomerulonephritis
    48. Drug Therapy Individualization for Patients with Chronic Kidney Disease
    49. Disorders of Sodium and Water Homeostasis
    50. Disorders of Calcium and Phosphorus Homeostasis
    51. Disorders of Potassium and Magnesium Homeostasis
    52. Acid–Base Disorders
    Section 6 Neurologic Disorders
    e53. Evaluation of Neurologic Illness
    54. Alzheimer Disease
    55. Multiple Sclerosis
    56. Epilepsy
    57. Status Epilepticus
    58. Acute Management of the Brain Injury Patient
    59. Parkinson Disease
    60. Pain Management
    61. Headache Disorders
    Section 7 Psychiatric Disorders
    e62. Assessment of Psychiatric Disorders
    63. Attention Deficit/Hyperactivity Disorder
    64. Eating Disorders
    65. Substance-Related Disorders I:: Overview and Depressants, Stimulants, and Hallucinogens
    66. Substance-Related Disorders II:: Alcohol, Nicotine, and Caffeine
    67. Schizophrenia
    68. Major Depressive Disorder
    69. Bipolar Disorder
    70. Anxiety Disorders:: Generalized Anxiety, Panic, and Social Anxiety Disorders
    71. Posttraumatic Stress Disorder and Obsessive-Compulsive Disorder
    72. Sleep–Wake Disorders
    73. Disorders Associated with Intellectual Disabilities
    Section 8 Endocrinologic Disorders
    74. Diabetes Mellitus
    75. Thyroid Disorders
    76. Adrenal Gland Disorders
    e77. Pituitary Gland Disorders
    Section 9 Gynecologic and Obstetric Disorders
    78. Pregnancy and Lactation:: Therapeutic Considerations
    79. Contraception
    80. Menstruation-Related Disorders
    81. Endometriosis
    82. Hormone Therapy in Women
    Section 10 Urologic Disorders
    83. Erectile Dysfunction
    84. Benign Prostatic Hyperplasia
    85. Urinary Incontinence
    Section 11 Immunologic Disorders
    e86. Function and Evaluation of the Immune System
    87. Systemic Lupus Erythematosus
    e88. Drug Allergy
    89. Solid-Organ Transplantation
    Section 12 Rheumatologic Disorders
    90. Osteoarthritis
    91. Rheumatoid Arthritis
    92. Osteoporosis and Osteomalacia
    93. Gout and Hyperuricemia
    Section 13 Ophthalmic and Otolaryngological Disorders
    94. Glaucoma
    95. Allergic Rhinitis
    Section 14 Dermatologic Disorders
    96. Acne Vulgaris
    97. Psoriasis
    98. Atopic Dermatitis
    e99. Dermatologic Drug Reactions and Common Skin Conditions
    Section 15 Hematologic Disorders
    100. Anemias
    101. Coagulation Disorders
    102. Sickle Cell Disease
    e103. Drug-Induced Hematologic Disorders
    Section 16 Infectious Diseases
    e104. Laboratory Tests to Direct Antimicrobial Pharmacotherapy
    105. Antimicrobial Regimen Selection
    106. Central Nervous System Infections
    107. Lower Respiratory Tract Infections
    108. Upper Respiratory Tract Infections
    109. Influenza
    110. Skin and Soft-Tissue Infections
    111. Infective Endocarditis
    112. Tuberculosis
    113. Gastrointestinal Infections and Enterotoxigenic Poisonings
    114. Intra-Abdominal Infections
    e115. Parasitic Diseases
    116. Urinary Tract Infections and Prostatitis
    117. Sexually Transmitted Diseases
    118. Bone and Joint Infections
    119. Sepsis and Septic Shock
    120. Superficial Fungal Infections
    121. Invasive Fungal Infections
    122. Infections in Immunocompromised Patients
    123. Antimicrobial Prophylaxis in Surgery
    e124. Travel Health
    125. Vaccines and Immunoglobulins
    126. Human Immunodeficiency Virus Infection
    Section 17 Oncologic Disorders
    127. Cancer Treatment and Chemotherapy
    128. Breast Cancer
    129. Lung Cancer
    130. Colorectal Cancer
    131. Prostate Cancer
    132. Lymphomas
    133. Ovarian Cancer
    134. Acute Leukemias
    135. Chronic Leukemias
    136. Multiple Myeloma
    e137. Myelodysplastic Syndromes
    e138. Renal Cell Carcinoma
    139. Melanoma
    140. Hematopoietic Stem Cell Transplantation
    Section 18 Nutritional Disorders
    141. Assessment of Nutrition Status and Nutrition Requirements
    142. Parenteral Nutrition
    143. Enteral Nutrition
    144. Obesity
    Index
Komentarze (0)